一个系统的审查的玻尿素毒素注射在儿科 dystonia 的系统审查
Andrea Rasera1, Giovanna Maddalena Squintani2, Maria Angela Cerruto3
1Neurology Unit, "Azienda Provinciale per i Servizi Sanitari", Trento "Santa Chiara" Hospital, Largo Medaglie d'oro 9, 38122 Trento, Italy.
Toxins
|July 26, 2024
概括
毒素 (BT) 显示出治疗儿科 dystonia 的前景,改善运动功能和生活质量,副作用最小. 需要进一步的研究来证实它在儿童中的有效性和安全性.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 药理学 药理学是指药理学的学科.
背景情况:
- 毒素 (BT) 是成人焦点 dystonias 的一线治疗方法.
- 美国食品和药物管理局批准用于小儿和,但在2岁以下的儿童中使用是非标签的.
- 儿科 dystonia 的剂量和治疗策略缺乏国际共识.
研究的目的:
- 评估BT治疗在儿科 dystonia (21岁以下) 的疗效和安全性.
- 审查BT在治疗儿童中孤立或相关的 dystonic 疾病方面的最佳可用证据.
主要方法:
- 在PubMed,Scopus和Web of Science的综合文献搜索.
- 包括12篇英语文章.
- 分析了来自57名患有 dystonia 的儿科患者的数据.
主要成果:
- 通过BT治疗,运动功能得到了改善.
- 在儿科患者中,BT可减轻疼痛,改善生活质量.
- 与BT治疗相关的不良影响是最小的.
结论:
- 尽管证据有限 (没有RCT),但BT似乎对儿科 dystonia 有效.
- 童年 dystonia 的异质性需要进一步的多中心试验.
- 需要更高层次的证据才能完全确定BT在儿科 dystonia 的疗效和安全性.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
664
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
664
Skeletal Muscle Relaxants: Therapeutic Uses
477
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
477
Depolarizing Blockers: Pharmocokinetics
317
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
317
Skeletal Muscle Relaxants: Adverse Effects
349
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
349
Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
Classification of Skeletal Muscle Relaxants
2.4K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.4K


